Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1956 Jun;11(2):175–179. doi: 10.1111/j.1476-5381.1956.tb01049.x

Some central actions of 5-hydroxytryptamine and various antagonists

J H Gaddum, M Vogt
PMCID: PMC1509579  PMID: 13329335

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMIN A. H., CRAWFORD T. B., GADDUM J. H. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol. 1954 Dec 10;126(3):596–618. doi: 10.1113/jphysiol.1954.sp005229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BONVALLET M., DELL P., HIEBEL G. Tonus sympathique et activité électrique corticale. Electroencephalogr Clin Neurophysiol. 1954 Feb;6(1):119–144. doi: 10.1016/0013-4694(54)90011-5. [DOI] [PubMed] [Google Scholar]
  3. CERLETTI A., ROTHLIN E. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature. 1955 Oct 22;176(4486):785–786. doi: 10.1038/176785a0. [DOI] [PubMed] [Google Scholar]
  4. FELDBERG W., SHERWOOD S. L. A permanent cannula for intraventricular injections in cats. J Physiol. 1953 Apr 28;120(1-2):3P–5P. [PubMed] [Google Scholar]
  5. GADDUM J. H. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine. J Physiol. 1953 Jul;121(1):15P–15P. [PubMed] [Google Scholar]
  6. KOSTERLITZ H. W., ROBINSON J. A. Mechanism of the contraction of the longitudinal muscle of the isolated guinea-pig ileum, caused by raising the pressure in the lumen. J Physiol. 1955 Jul 28;129(1):18–9P. [PubMed] [Google Scholar]
  7. PAASONEN M. K., VOGT M. The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J Physiol. 1956 Mar 28;131(3):617–626. doi: 10.1113/jphysiol.1956.sp005486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PLETSCHER A., SHORE P. A., BRODIE B. B. Serotonin release as a possible mechanism of reserpine action. Science. 1955 Aug 26;122(3165):374–375. doi: 10.1126/science.122.3165.374. [DOI] [PubMed] [Google Scholar]
  9. SHAW E., WOOLLEY D. W. Pharmacological properties of some antimetabolites of serotonin having unusually high activity on isolated tissues. J Pharmacol Exp Ther. 1954 May;111(1):43–53. [PubMed] [Google Scholar]
  10. SHORE P. A., SILVER S. L., BRODIE B. B. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science. 1955 Aug 12;122(3163):284–285. doi: 10.1126/science.122.3163.284-a. [DOI] [PubMed] [Google Scholar]
  11. TWAROG B. M., PAGE I. H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol. 1953 Oct;175(1):157–161. doi: 10.1152/ajplegacy.1953.175.1.157. [DOI] [PubMed] [Google Scholar]
  12. WOOLLEY D. W., SHAW E. Some neurophysiological aspects of serotonin. Br Med J. 1954 Jul 17;2(4880):122–126. doi: 10.1136/bmj.2.4880.122. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES